Cargando…
Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients
BACKGROUND: Gene expression of peripheral myelin protein 22 (PMP22) and the epithelial membrane proteins (EMPs) was found to be differentially expressed in invasive and non-invasive breast cell lines in a previous study. We want to evaluate the prognostic impact of the expression of these genes on b...
Autores principales: | Tong, Dan, Heinze, Georg, Pils, Dietmar, Wolf, Andrea, Singer, Christian F, Concin, Nicole, Hofstetter, Gerda, Schiebel, Ingrid, Rudas, Margaretha, Zeillinger, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018461/ https://www.ncbi.nlm.nih.gov/pubmed/21159173 http://dx.doi.org/10.1186/1471-2407-10-682 |
Ejemplares similares
-
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
por: Pils, Dietmar, et al.
Publicado: (2013) -
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014) -
RUNX represses Pmp22 to drive neurofibromagenesis
por: Hall, Ashley, et al.
Publicado: (2019) -
Nomogram prediction for overall survival of patients diagnosed with cervical cancer
por: Polterauer, S, et al.
Publicado: (2012) -
PMP22 exon 4 deletion causes ER retention of PMP22 and a gain‐of‐function allele in CMT1E
por: Wang, David S., et al.
Publicado: (2017)